Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.
SB1743 • 2026
CLINIC PSYC-NO PRESCRIP OPIOID
This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.
Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.
CLINIC PSYC-NO PRESCRIP OPIOID
These notes stay tied to the official amendment files and metadata from the legislature.
Plain English: Illinois General Assembly - Full Text of SB1743 Select Language × The Illinois General Assembly offers the Google Translate™ service for visitor convenience.
Sent to the Governor
Third Reading - Short Debate - Passed 067-031-000
Passed Both Houses
Second Reading - Short Debate
Placed on Calendar Order of 3rd Reading - Short Debate
Do Pass / Short Debate Health Care Licenses Committee ; 010-004-000
Placed on Calendar 2nd Reading - Short Debate
Committee Deadline Extended-Rule 9(b) May 15, 2026
First Reading
Referred to Rules Committee
Assigned to Health Care Licenses Committee
Chief House Sponsor Rep. Maurice A. West, II
Third Reading - Passed; 052-001-000
Arrived in House
Rule 2-10 Third Reading Deadline Established As May 8, 2026
Second Reading
Placed on Calendar Order of 3rd Reading April 28, 2026
Senate Committee Amendment No. 1 Adopted
Do Pass as Amended Licensed Activities ; 008-000-001
Placed on Calendar Order of 2nd Reading April 16, 2026
Rule 2-10 Committee Deadline Established As April 24, 2026
Senate Committee Amendment No. 1 Assignments Refers to Licensed Activities
Added as Chief Co-Sponsor Sen. Dave Syverson
Senate Committee Amendment No. 1 Filed with Secretary by Sen. Lakesia Collins
Senate Committee Amendment No. 1 Referred to Assignments
Rule 2-10 Committee Deadline Established As March 27, 2026
Re-assigned to Licensed Activities
Rule 3-9(a) / Re-referred to Assignments
Rule 2-10 Committee/3rd Reading Deadline Established As June 1, 2025
Rule 2-10 Committee/3rd Reading Deadline Established As May 23, 2025
Rule 2-10 Committee/3rd Reading Deadline Established As May 9, 2025
Rule 2-10 Committee Deadline Established As April 11, 2025
Rule 2-10 Committee Deadline Established As April 4, 2025
Assigned to Licensed Activities
Filed with Secretary by Sen. Lakesia Collins
First Reading
Referred to Assignments
CLINIC PSYC-NO PRESCRIP OPIOID
Illinois General Assembly - Full Text of SB1743 Select Language × The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein. Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet. The English language version is always the official and authoritative version of this website. NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window. Choose Language English Afrikaans Albanian Arabic Armenian Azerbaijani Basque Bengali Bosnian Catalan Croatian Czech Danish Dutch Esperanto Estonian Filipino Finnish French Galician Georgian German Greek Gujarati Haitian Creole Hausa Hawaiian Hebrew Hindi Hungarian Icelandic Indonesian Interlingua Interlingue Inuktitut Irish Italian Japanese Javanese Kannada Khmer Korean Latin Latvian Lithuanian Luxembourgish Macedonian Malagasy Malayalam Maltese Maori Marathi Myanmar Nepali Norwegian Odia Pashto Punjabi Romanian Russian Samoan Sango Sanskrit Sardinian Sindhi Sinhala Slovak Slovenian Somali Southern Sotho Spanish Sundanese Swahili Swedish Tamil Telugu Thai Tigrinya Tonga Turkish Ukrainian Urdu Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Powered by Translate Close Illinois General Assembly Top Navigation Bar Translate Learn Select General Assembly Search the 104th General Assembly Enter search terms for legislation, members, committees, or schedules. ILGA.GOV LEGISLATION & LAWS Bills & Resolutions Public Acts Illinois Compiled Statutes Illinois Constitution Search Legislation Glossary Guide Reports & Inquiry Legislative Reports Special Reports FTP Site Legislator Lookup Capitol Complex Phone Numbers Rules & Regulations Illinois Register Administrative Rules Senate Members Schedules Committees Request for Remote Testimony Journals Transcripts Rules Audio/Video FOIA Information Senate Employment Opportunities Media Guidelines House Members Schedules Committees Submit testimony for House Committees Journals Transcripts Rules Audio/Video FOIA Information House Employment Opportunities Log In Mobile Top Bar Search the 104th General Assembly Enter keywords to search the Illinois General Assembly website. Full Text of SB1743 Home Legislation Full Text SB1743 - 104th General Assembly Bill Status Full Text Votes Witness Slips Select Menu Bill Status Full Text Votes Witness Slips Printer Friendly Version Introduced Engrossed Enrolled Senate Amendment 001 Printer Friendly Version Introduced Engrossed Enrolled Senate Amendment 001 Open PDF SB1743 Enrolled LRB104 11917 AAS 22009 b 1 AN ACT concerning regulation. 2 Be it enacted by the People of the State of Illinois, 3 represented in the General Assembly: 4 Section 5. The Clinical Psychologist Licensing Act is 5 amended by changing Section 4.3 as follows: 6 (225 ILCS 15/4.3) 7 (Section scheduled to be repealed on January 1, 2027) 8 Sec. 4.3. Written collaborative agreements. 9 (a) A written collaborative agreement is required for all 10 prescribing psychologists practicing under a prescribing 11 psychologist license issued pursuant to Section 4.2 of this 12 Act. 13 (b) A written delegation of prescriptive authority by a 14 collaborating physician may only include medications for the 15 treatment of mental health disease or illness the 16 collaborating physician generally provides to his or her 17 patients in the normal course of his or her clinical practice 18 with the exception of the following: 19 (1) patients who are less than 17 years of age or over 20 65 years of age ; 21 (2) patients during pregnancy; 22 (3) patients with serious medical conditions, such as 23 heart disease, cancer, stroke, or seizures, and with SB1743 Enrolled - 2 - LRB104 11917 AAS 22009 b 1 developmental disabilities and intellectual disabilities; 2 and 3 (4) prescriptive authority for benzodiazepine Schedule 4 III controlled substances. 5 (c) The collaborating physician shall file with the 6 Department notice of delegation of prescriptive authority and 7 termination of the delegation, in accordance with rules of the 8 Department. Upon receipt of this notice delegating authority 9 to prescribe any nonnarcotic Schedule III through V controlled 10 substances, the licensed clinical psychologist shall be 11 eligible to register for a mid-level practitioner controlled 12 substance license under Section 303.05 of the Illinois 13 Controlled Substances Act. 14 (d) All of the following shall apply to delegation of 15 prescriptive authority: 16 (1) Any delegation of Schedule III through V 17 controlled substances shall identify the specific 18 controlled substance by brand name or generic name. No 19 controlled substance to be delivered by injection may be 20 delegated. No Schedule II controlled substance shall be 21 delegated. 22 (2) A prescribing psychologist shall not prescribe 23 narcotic drugs, as defined in Section 102 of the Illinois 24 Controlled Substances Act. 25 Any prescribing psychologist who writes a prescription for 26 a controlled substance without having valid and appropriate SB1743 Enrolled - 3 - LRB104 11917 AAS 22009 b 1 authority may be fined by the Department not more than $50 per 2 prescription and the Department may take any other 3 disciplinary action provided for in this Act. 4 All prescriptions written by a prescribing psychologist 5 must contain the name of the prescribing psychologist and his 6 or her signature. The prescribing psychologist shall sign his 7 or her own name. 8 (e) The written collaborative agreement shall describe the 9 working relationship of the prescribing psychologist with the 10 collaborating physician and shall delegate prescriptive 11 authority as provided in this Act. Collaboration does not 12 require an employment relationship between the collaborating 13 physician and prescribing psychologist. Absent an employment 14 relationship, an agreement may not restrict third-party 15 payment sources accepted by the prescribing psychologist. For 16 the purposes of this Section, "collaboration" means the 17 relationship between a prescribing psychologist and a 18 collaborating physician with respect to the delivery of 19 prescribing services in accordance with (1) the prescribing 20 psychologist's training, education, and experience and (2) 21 collaboration and consultation as documented in a jointly 22 developed written collaborative agreement. 23 (f) The agreement shall promote the exercise of 24 professional judgment by the prescribing psychologist 25 corresponding to his or her education and experience. 26 (g) The collaborative agreement shall not be construed to SB1743 Enrolled - 4 - LRB104 11917 AAS 22009 b 1 require the personal presence of a physician at the place 2 where services are rendered. Methods of communication shall be 3 available for consultation with the collaborating physician in 4 person or by telecommunications in accordance with established 5 written guidelines as set forth in the written agreement. 6 (h) Collaboration and consultation pursuant to all 7 collaboration agreements shall be adequate if a collaborating 8 physician does each of the following: 9 (1) participates in the joint formulation and joint 10 approval of orders or guidelines with the prescribing 11 psychologist and he or she periodically reviews the 12 prescribing psychologist's orders and the services 13 provided patients under the orders in accordance with 14 accepted standards of medical practice and prescribing 15 psychologist practice; 16 (2) provides collaboration and consultation with the 17 prescribing psychologist in person at least once a month 18 for review of safety and quality clinical care or 19 treatment; 20 (3) is available through telecommunications for 21 consultation on medical problems, complications, 22 emergencies, or patient referral; and 23 (4) reviews medication orders of the prescribing 24 psychologist no less than monthly, including review of 25 laboratory tests and other tests as available. 26 (i) The written collaborative agreement shall contain SB1743 Enrolled - 5 - LRB104 11917 AAS 22009 b 1 provisions detailing notice for termination or change of 2 status involving a written collaborative agreement, except 3 when the notice is given for just cause. 4 (j) A copy of the signed written collaborative agreement 5 shall be available to the Department upon request to either 6 the prescribing psychologist or the collaborating physician. 7 (k) Nothing in this Section shall be construed to limit 8 the authority of a prescribing psychologist to perform all 9 duties authorized under this Act. 10 (l) A prescribing psychologist shall inform each 11 collaborating physician of all collaborative agreements he or 12 she has signed and provide a copy of these to any collaborating 13 physician. 14 (m) No collaborating physician shall enter into more than 15 3 collaborative agreements with prescribing psychologists. 16 (Source: P.A. 101-84, eff. 7-19-19.) 17 Section 99. Effective date. This Act takes effect upon 18 becoming law. Footer Disclaimer This site is maintained for the Illinois General Assembly by the Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706. Contact ILGA Webmaster ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies. Read About Cookies ILGA.GOV 2026 ILGA.gov | All Rights Reserved | ADA | Disclaimers | Learn This site is maintained for the Illinois General Assembly by the Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706. Contact ILGA Webmaster ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies. Read About Cookies ILGA.GOV 2026 ILGA.gov | All Rights Reserved | ADA | Disclaimers | Learn